MDT Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$98.84median target· current $92.21 (+7.2%)29 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
24 articles · sorted by datePage 1 of 2 · 24 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio24.35Forward 15.11
EPS (TTM)$3.7818.3% YoY
Profit margin13.2%HEALTHCARE
Market cap$117.81BLarge cap
Valuation
- Forward P/E
- 15.11
- PEG ratio
- 1.78
- P/B
- 2.33
- P/S (TTM)
- 3.24
- EV/EBITDA
- 13.65
Profitability & growth
- ROE (TTM)
- 9.8%
- Operating margin
- 22.1%
- Revenue growth YoY
- 9.9%
- Dividend yield
- 0.0%
- Beta
- 0.57
Last earnings
Aug 18, 2026 · Estimate $1.39 · Reported $1.45
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Medtronic PLC
Company profileMedtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- BUILDING TWO, GALWAY, IRELAND
- Fiscal year end
- April
- Latest quarter
- Apr 30, 2026
Market cap$117.81B
Shares outstanding$1.28B
52W high$103.76
52W low$72.65
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent